Brain DisorderNCT07397767
Development of Quantitative Parameter of Upper Extremity Function in Patients With Brain Disorder Using Smart-Board and Smart-Glove.
A study testing smart device in people with Brain Disorder and Smart Device Rehabilitation, run by Samsung Medical Center at 1 site in South Korea.
Trial summary
The aim of this study is to develop a novel quantitative metric for assessing upper-limb function in patients with neurological disorders. This will be accomplished by analyzing performance data obtained from a smart board and smart glove system and comparing these data with conventional clinical assessment methods… Read more about this study
- Who is it for?
- Ages 19 years and older
- Conditions the study is for
- Brain Disorder, Smart Device Rehabilitation
- What is being tested?
- smart device
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 150 participants
- Where
- 1 siteSouth Korea
- Study dates
- 7 Feb 2024to 31 Dec 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 19 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Adults aged 19 years or older.
- Patients with upper-limb functional impairment due to neurological conditions such as stroke, cerebral palsy, brain tumor, traumatic brain injury, or Parkinson's disease.
Who cannot join
- Patients with progressive neurological disorders or those in a state of hemodynamic instability.
- Patients with severe cognitive impairment (MMSE < 10) or significant communication difficulty due to language disorders.
- Any other condition in which the investigator determines that participation in the study is inappropriate.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Development of Quantitative Parameter of Upper Extremity Function in Patients With Brain Disorder Using Smart-Board and Smart-Glove, Single-Center, Prospective Study
The aim of this study is to develop a novel quantitative metric for assessing upper-limb function in patients with neurological disorders. This will be accomplished by analyzing performance data obtained from a smart board and smart glove system and comparing these data with conventional clinical assessment methods currently used to evaluate upper-limb impairment.
- Conditions
- Brain Disorder, Smart Device Rehabilitation
- Being tested
- smart device
- Medical subject headings
- Brain Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
smart deviceDevice
Participants will undergo two sessions of upper-limb movement assessment using the smart board and smart glove on the day of the clinical trial. Simultaneously, video recordings will be obtained using a mobile camera. These procedures will be used to collect quantitative data on upper-limb movements.
| Study group | Role | What they receive |
|---|---|---|
| Smart Device User | Experimental | Smart Device User Receives: Device: smart device |
What is being measured
The primary outcome is the main question the study is designed to answer.
validity
To examine the correlation between the primary outcome measure (FM-UE) and the trunk rehabilitation assessment model derived from mobile camera, smart board, and smart glove data.
Measured: the day of the study procedures
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Feb 2026
- Study start7 Feb 2024
- Primary completion23 Dec 2025
- Study completion31 Dec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Brain DisorderStudies of the same condition, open and under way.
- More trials run by Samsung Medical CenterThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Diagnosis
- Allocation
- Not applicable
- Intervention model
- Sequential
- Masking
- None (open label)
- Enrolment
- 150 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Samsung Medical Center
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Won Hyuk Chang, Samsung Medical Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07397767
- Sponsor's protocol ID
- 2023-11-105
- Other IDs
- RS-2023-00248118
- Status last verified
- Feb 2026
- First submitted
- 20 Jan 2026
- Last updated
- 9 Feb 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 9 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Development of Quantitative Parameter of Upper Extremity Function in Patients With Brain Disorder Using Smart-Board and Smart-Glove, Single-Center, Prospective Study
- ClinicalTrials.gov ID
- NCT07397767
- Acronym / sponsor ID
- 2023-11-105
- Conditions
- Brain Disorder, Smart Device Rehabilitation
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 150 participants (estimated)
- Lead sponsor
- Samsung Medical CenterUniversity, hospital or other
- Study start
- 7 Feb 2024 (actual)
- Primary completion
- 23 Dec 2025 (actual)
- Study completion
- 31 Dec 2026 (estimated)
- First posted
- 9 Feb 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this study is to develop a novel quantitative metric for assessing upper-limb function in patients with neurological disorders. This will be accomplished by analyzing performance data obtained from a smart board and smart glove system and comparing these data with conventional clinical assessment methods currently used to evaluate upper-limb impairment.
Study design
- Primary purpose
- Diagnosis
- Allocation
- Not applicable
- Intervention model
- Sequential
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Smart Device User | Experimental | Device: smart deviceSmart Device User |
Who may qualify
- Ages
- 19 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- Adults aged 19 years or older.
- Patients with upper-limb functional impairment due to neurological conditions such as stroke, cerebral palsy, brain tumor, traumatic brain injury, or Parkinson's disease.
Key exclusion criteria (3 listed)
- Patients with progressive neurological disorders or those in a state of hemodynamic instability.
- Patients with severe cognitive impairment (MMSE < 10) or significant communication difficulty due to language disorders.
- Any other condition in which the investigator determines that participation in the study is inappropriate.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| smart deviceParticipants will undergo two sessions of upper-limb movement assessment using the smart board and smart glove on the day of the clinical trial. Simultaneously, video recordings will be obtained using a mobile camera. These procedures will be used to collect quantitative data on upper-limb movements. | Device | Smart Device User |
Primary outcome
validity
Time frame: the day of the study procedures
To examine the correlation between the primary outcome measure (FM-UE) and the trunk rehabilitation assessment model derived from mobile camera, smart board, and smart glove data.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Feb 2026.
Related trials for Brain Disorder
Recruiting
Efficacy and Safety of Ischemic Preconditioning Therapy Versus Optimal Medical Therapy in Reducing the Recurrence of Ischemic Events in Symptomatic Moyamoya Disease
Moya Moya Disease, Moyamoya Syndrome
RecruitingPhase 2
A Clinical Trial Testing the Safety of the Investigational Drug Pumitamig (BNT327) and How Well it Works in Patients With Recurrent Glioblastoma
Recurrent Glioblastoma
RecruitingPhase 1/2
Safety and Efficacy of CG-BM1 in Ischemic Stroke
Ischemic Stroke or High-risk TIA (ABCD² ≥ 4)
Not yet recruitingPhase 3
Recombinant Human Prourokinase for Acute Ischemic Stroke in the Extended Window Selected by CT-Based Artificial Intelligence
Acute Ischemic Stroke
RecruitingObservational study
Studies of the Variable Phenotypic Presentations of Rapid-Onset Dystonia Parkinsonism and Other Movement Disorders
Dystonia, Parkinsonism
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing smart device in people with Brain Disorder and Smart Device Rehabilitation, run by Samsung Medical Center at 1 site in South Korea.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 9 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
validity (time frame: the day of the study procedures). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Feb 2026.